Send the following on WhatsApp
Continue to ChatThe effect of anti TNF alpha (certolizumab) treatment on insulin resistance, lipid parameters and cardiovascular risk in patients with axial spondyloarthritis (ankylosing spondylitis) - https://dergipark.org.tr/tr/pub/dahudermj/issue/71504/1146178